About
Generics, Specialty
Areas of Focus
Categories
Generic DrugAustria
Clinical Trials (15)
View allTotal Trials
15
As Lead Sponsor
10
As Collaborator
5
Total Enrollment
5,605
By Phase
EARLY_PHASE1: 1PHASE2: 3PHASE4: 7PHASE3: 2
By Status
COMPLETED: 7TERMINATED: 3NOT_YET_RECRUITING: 2ACTIVE_NOT_RECRUITING: 1RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06489925Collaborator
Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion
EARLY_PHASE1Not yet recruiting
20 participants
Started: Jul 31, 2024 · Completed: May 31, 2026
NCT05755997Lead Sponsor
CERebrolysin In CADASIL
PHASE2Active, not recruiting
30 participants
Started: Nov 29, 2023 · Completed: Dec 31, 2026
NCT04427241Collaborator
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness
PHASE4Not yet recruiting
12 participants
Started: Jun 1, 2023 · Completed: Dec 31, 2025
NCT06273020Collaborator
Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke
PHASE4Recruiting
60 participants
Started: Nov 17, 2022 · Completed: Dec 31, 2024
NCT04124367Lead Sponsor
IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE
PHASE2Terminated
4 participants
Started: Jun 25, 2021 · Completed: Mar 21, 2022
Locations (1)
Headquarters
Unterach, Austria
Map
Loading map...